Investing carries serious risks, including partial or total loss of capital. Please read the Information Note and the Risk factors and login before investing.

YNIOS Pharma 1A

Equity
€107,500
total amount raised
  • Backed by over 70 investors
  • Benefits from the Tax Shelter advantage
This campaign ended

Jean F Plucker

Co-founder

Philippe Van Wesepoel

Co-founder

TAX SHELTER 45%

Investments in this company benefit from a 45% Tax Shelter reduction from your personal income taxes. Read more…
Please note €393,500 remains available for Tax Shelter investments.

Raise summary

Crowd investments €107,500
Committed by others €0
Amount raised €107,500
Minimum round €50,000
Maximum round €500,000
Shares in the company (total round) 8.518%
Pre-money valuation €5,370,000
Post-money valuation min. €5,420,000
Post-money valuation max. €5,870,000